These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 23603111

  • 1. Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.
    Kumar S, Patel R, Moore S, Crawford DK, Suwanna N, Mangiardi M, Tiwari-Woodruff SK.
    Neurobiol Dis; 2013 Aug; 56():131-44. PubMed ID: 23603111
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Multiple functional therapeutic effects of the estrogen receptor β agonist indazole-Cl in a mouse model of multiple sclerosis.
    Moore SM, Khalaj AJ, Kumar S, Winchester Z, Yoon J, Yoo T, Martinez-Torres L, Yasui N, Katzenellenbogen JA, Tiwari-Woodruff SK.
    Proc Natl Acad Sci U S A; 2014 Dec 16; 111(50):18061-6. PubMed ID: 25453074
    [Abstract] [Full Text] [Related]

  • 7. Increase in chemokine CXCL1 by ERβ ligand treatment is a key mediator in promoting axon myelination.
    Karim H, Kim SH, Lapato AS, Yasui N, Katzenellenbogen JA, Tiwari-Woodruff SK.
    Proc Natl Acad Sci U S A; 2018 Jun 12; 115(24):6291-6296. PubMed ID: 29844175
    [Abstract] [Full Text] [Related]

  • 8. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models.
    Rajendran R, Böttiger G, Stadelmann C, Karnati S, Berghoff M.
    Cells; 2021 Apr 13; 10(4):. PubMed ID: 33924474
    [Abstract] [Full Text] [Related]

  • 9. Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis.
    Giacoppo S, Pollastro F, Grassi G, Bramanti P, Mazzon E.
    Fitoterapia; 2017 Jan 13; 116():77-84. PubMed ID: 27890794
    [Abstract] [Full Text] [Related]

  • 10. Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis.
    Zhang J, Zhang ZG, Li Y, Ding X, Shang X, Lu M, Elias SB, Chopp M.
    Neurobiol Dis; 2015 Apr 13; 76():57-66. PubMed ID: 25680941
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis.
    Kerstetter AE, Padovani-Claudio DA, Bai L, Miller RH.
    Exp Neurol; 2009 Nov 13; 220(1):44-56. PubMed ID: 19616545
    [Abstract] [Full Text] [Related]

  • 12. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
    Najm FJ, Madhavan M, Zaremba A, Shick E, Karl RT, Factor DC, Miller TE, Nevin ZS, Kantor C, Sargent A, Quick KL, Schlatzer DM, Tang H, Papoian R, Brimacombe KR, Shen M, Boxer MB, Jadhav A, Robinson AP, Podojil JR, Miller SD, Miller RH, Tesar PJ.
    Nature; 2015 Jun 11; 522(7555):216-20. PubMed ID: 25896324
    [Abstract] [Full Text] [Related]

  • 13. Bu Shen Yi Sui capsule promotes remyelination correlating with Sema3A/NRP-1, LIF/LIFR and Nkx6.2 in mice with experimental autoimmune encephalomyelitis.
    Zhao PY, Wang YQ, Liu XH, Zhu YJ, Zhao H, Zhang QX, Qi F, Li JL, Zhang N, Fan YP, Li KN, Zhao YY, Lei JF, Wang L.
    J Ethnopharmacol; 2018 May 10; 217():36-48. PubMed ID: 29428242
    [Abstract] [Full Text] [Related]

  • 14. G protein-coupled receptor 30 contributes to improved remyelination after cuprizone-induced demyelination.
    Hirahara Y, Matsuda KI, Yamada H, Saitou A, Morisaki S, Takanami K, Boggs JM, Kawata M.
    Glia; 2013 Mar 10; 61(3):420-31. PubMed ID: 23281138
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neuregulin in neuron/glial interactions in the central nervous system. GGF2 diminishes autoimmune demyelination, promotes oligodendrocyte progenitor expansion, and enhances remyelination.
    Marchionni MA, Cannella B, Hoban C, Gao YL, Garcia-Arenas R, Lawson D, Happel E, Noel F, Tofilon P, Gwynne D, Raine CS.
    Adv Exp Med Biol; 1999 Mar 10; 468():283-95. PubMed ID: 10635037
    [Abstract] [Full Text] [Related]

  • 17. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
    Butzkueven H, Emery B, Cipriani T, Marriott MP, Kilpatrick TJ.
    Glia; 2006 May 10; 53(7):696-703. PubMed ID: 16498619
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination.
    Narayanan SP, Flores AI, Wang F, Macklin WB.
    J Neurosci; 2009 May 27; 29(21):6860-70. PubMed ID: 19474313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.